特一药业
(002728)
| 流通市值：31.66亿 | | | 总市值：43.11亿 |
| 流通股本：3.76亿 | | | 总股本：5.13亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 230,161,408.15 | 457,414,315.11 | 384,881,891.18 | 407,246,040.2 |
| 应收票据及应收账款 | 188,394,058.76 | 205,321,950.87 | 132,792,589.38 | 116,765,737.13 |
| 其中：应收票据 | 98,367,204.92 | 106,575,601.48 | 57,018,214.01 | 46,912,039.32 |
| 应收账款 | 90,026,853.84 | 98,746,349.39 | 75,774,375.37 | 69,853,697.81 |
| 预付款项 | 25,992,347.79 | 10,403,104.32 | 18,044,961.85 | 14,266,189.61 |
| 其他应收款合计 | 1,395,952.73 | 9,375,183 | 1,301,281.88 | 1,704,665.68 |
| 其中:应收利息 | 295,136.99 | 458,221.92 | 686,950.68 | 1,211,273.97 |
| 存货 | 275,775,649.5 | 264,377,722.25 | 291,610,818.03 | 311,320,398.3 |
| 其他流动资产 | 5,896,657.4 | 4,054,787.91 | 4,042,666.26 | 6,834,658.54 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 777,616,074.33 | 950,947,063.46 | 1,047,674,208.58 | 965,137,689.46 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 13,500,000 | 13,500,000 | 13,500,000 | 13,500,000 |
| 投资性房地产 | 7,708,905.96 | 9,141,872.07 | 9,263,429.84 | 9,384,938.28 |
| 固定资产 | 553,286,470.76 | 563,512,848.94 | 511,450,406.18 | 512,213,879.84 |
| 在建工程 | 157,131,390.58 | 157,882,304.69 | 173,744,602.18 | 175,640,171.69 |
| 无形资产 | 135,532,941.17 | 138,631,569.26 | 141,768,334.79 | 144,926,462.83 |
| 开发支出 | 21,172,691.72 | 17,407,880.4 | 14,688,155.11 | 14,532,815.3 |
| 商誉 | 517,600,671.3 | 517,600,671.3 | 529,228,239.78 | 529,228,239.78 |
| 长期待摊费用 | - | - | - | 17,500.19 |
| 递延所得税资产 | 23,904,996.05 | 21,852,750.97 | 26,442,193.45 | 22,767,053.84 |
| 其他非流动资产 | 14,459,458.18 | 10,398,863.1 | 23,510,789.91 | 20,494,512.4 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,444,297,525.72 | 1,449,928,760.73 | 1,443,596,151.24 | 1,442,705,574.15 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,221,913,600.05 | 2,400,875,824.19 | 2,491,270,359.82 | 2,407,843,263.61 |
| 流动负债: | | | | |
| 短期借款 | 260,000,000 | 516,093,372.63 | 640,000,000 | 453,000,000 |
| 应付票据及应付账款 | 69,655,777.56 | 44,827,936.52 | 40,997,605.88 | 59,577,465.04 |
| 其中：应付票据 | 8,679,364.5 | 10,325,108.2 | 16,652,690.65 | 24,399,908.85 |
| 应付账款 | 60,976,413.06 | 34,502,828.32 | 24,344,915.23 | 35,177,556.19 |
| 合同负债 | 26,758,633.23 | 11,049,015.76 | 15,508,414.42 | 13,848,708.01 |
| 应付职工薪酬 | 7,996,672.75 | 9,408,041.89 | 5,845,424.79 | 6,934,500.31 |
| 应交税费 | 13,433,047.48 | 10,422,298.29 | 8,061,342.31 | 6,516,155.22 |
| 其他应付款合计 | 3,082,098.48 | 2,788,875.22 | 2,755,652.83 | 3,107,549.91 |
| 其他流动负债 | 3,478,622.32 | 1,429,209.52 | 2,016,093.88 | 1,798,954.65 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 384,404,851.82 | 596,018,749.83 | 715,184,534.11 | 544,783,333.14 |
| 非流动负债: | | | | |
| 递延收益 | 19,750,133.4 | 20,568,580.93 | 19,307,520.95 | 19,771,496.34 |
| 递延所得税负债 | 19,278,646.88 | 19,355,254.86 | 15,184,111.29 | 15,262,420.01 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 39,028,780.28 | 39,923,835.79 | 34,491,632.24 | 35,033,916.35 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 423,433,632.1 | 635,942,585.62 | 749,676,166.35 | 579,817,249.49 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 512,531,525 | 512,210,211 | 510,700,274 | 510,693,274 |
| 资本公积 | 845,809,732.9 | 844,126,047.54 | 836,879,220.77 | 836,842,540.77 |
| 减:库存股 | 93,947,845.02 | 93,856,250.88 | 93,856,250.88 | 3,984,608.42 |
| 专项储备 | 6,715,927.26 | 6,649,876.75 | 6,552,798.49 | 6,477,026.09 |
| 盈余公积 | 142,309,314.62 | 142,309,314.62 | 140,177,741.96 | 140,177,741.96 |
| 未分配利润 | 385,061,313.19 | 353,494,039.54 | 341,140,409.13 | 337,820,039.72 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,798,479,967.95 | 1,764,933,238.57 | 1,741,594,193.47 | 1,828,026,014.12 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,798,479,967.95 | 1,764,933,238.57 | 1,741,594,193.47 | 1,828,026,014.12 |
| 负债和股东权益合计 | 2,221,913,600.05 | 2,400,875,824.19 | 2,491,270,359.82 | 2,407,843,263.61 |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-26 | 2024-07-26 |
| 审计意见(境内) | | 标准无保留意见 | | |